Company details

argenx SE

  • Print
  • Share Share
en nl

We are rapidly creating and developing a pipeline of differentiated antibody therapeutics using our suite of powerful, cutting-edge technologies.

Our unique capabilities have enabled us to build a clinical-stage portfolio of novel product candidates – tailored from discovery through development to address patient and payer needs.